Investor's Business Daily on MSN
BioMarin soars 20% after folding in the $4.8 billion takeover of Amicus
BioMarin said Friday it will acquire Amicus Therapeutics for $4.8 billion in a deal that adds two rare disease drugs to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results